Anti-Topoisomerase II (Ki-S1) Monoclonal Antibody, Unconjugated, Clone P-tyr-I from CHEMICON

GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen

(Miller's LB Broth Base) Luria Broth Base powder from Invitrogen

Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen

LB Broth Base powder (Lennox L Broth Base) from Invitrogen

(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with

(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b

(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today

...researchers have developed a computer modeling app... antibodies, molecules key to the immune system. T...body that will improve its effectiveness. , The ...rsion of cetuximab, a drug commonly used to treat ...0 times greater affinity than the original molecul...

... bioMETRX, Inc. (OTC,Bulletin Board: BMRX) a lead... today announced that it has acquired a patent tha...ecure portable locks. The company believes that t.... For many years, consumers have been using portab...to secure personal belongings in lockers,and stora...

..., Sept. 10 ,Communication Intelligence Corporation...lier of electronic signature solutions for busines... the recognized leader in biometric,signature veri...el Betts to,the CIC Board of Directors. Mr. Betts...and,financial services industries and holds the FL...

(Date:12/4/2009)NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chroni

(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb

(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h

(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s